AmerisourceBergen Changes Name to Cencora
Shift comes with $5 million dedication to launch Cencora’s healthier futures grant program.
Cencora Inc., broke the news that it has completed a name and stock ticker change from AmerisourceBergen Corporation. As part of the announcement, Cencora plans on donating $5 million to the Cencora Impact Foundation, with the purpose of launching the Cencora Healthier Futures Grant Program. The program will aim to dentify opportunities to support those on the front lines of healthcare in underserved populations who are driving innovation in global health.
"Today is a significant and exciting milestone for Cencora. Our new name is a reminder of our customers, their patients, and our team members who are at the center of everything we do,” said Steven H. Collis, chairman, president, CEO, Cencora. “It represents the healthier futures we strive for serving as a trusted industry partner that prioritizes innovation, advocates for patient access, and advances strategic partnerships across the global pharmaceutical value chain.”
Reference: AmerisourceBergen becomes Cencora, in alignment with the company’s growing global footprint and central role in pharmaceutical access and care. Cencora. August 30, 2023. Accessed August 31, 2023. https://www.cencora.com/newsroom/press-releases/amerisourcebergen-becomes-cencora
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
